Core Viewpoint - Macro Medical Management (09906) anticipates a net loss attributable to shareholders not exceeding RMB 2 million for the six months ending June 30, 2025, compared to a net profit of approximately RMB 20 million for the six months ending June 30, 2024 [1] Group 1 - The expected shift from profit to loss is primarily due to a decrease in demand for inpatient medical services, leading to reduced revenue [1] - The actual settlement rate from the public medical insurance plan for the fiscal year 2024, completed in May 2025, was lower than the estimated settlement rate used in the consolidated financial statements for the year ending December 31, 2024, resulting in decreased inpatient service revenue [1] - The company further adjusted the estimated settlement rate for inpatient service revenue covered by the plan for the first half of 2025 downward due to the aforementioned discrepancies [1]

Core Viewpoint - The company expects to report a net loss attributable to shareholders of no more than RMB 2 million for the six months ending June 30, 2025, a significant decline from a net profit of approximately RMB 20 million for the same period in 2024 [1] Group 1: Financial Performance - The anticipated shift from profit to loss is primarily attributed to a decrease in demand for inpatient medical services, leading to reduced revenue [1] - The actual settlement rate from the 2024 public medical insurance plan, completed in May 2025, was lower than the estimated settlement rate used in the financial statements for the year ending December 31, 2024, resulting in decreased inpatient service revenue [1] - The company has further adjusted the estimated settlement rate for inpatient service revenue covered by the plan for the first half of 2025 downward [1]

Core Viewpoint - The company, Hongli Medical Management, anticipates a net loss attributable to shareholders of no more than RMB 2 million for the six months ending June 30, 2025, a significant decline from a net profit of approximately RMB 20 million for the same period in 2024 [1] Group 1: Financial Performance - The expected shift from profit to loss is primarily attributed to a decrease in demand for inpatient medical services, leading to reduced revenue [1] - The actual settlement rates from the public medical insurance plan for the fiscal year 2024, completed in May 2025, were lower than the estimated settlement rates used in the consolidated financial statements for the year ending December 31, 2024, resulting in decreased inpatient service revenue [1] - The company further adjusted the estimated settlement rates for inpatient service revenue covered by the plan for the first half of 2025 downward due to the aforementioned discrepancies [1]